institutional investors

Filter by:
All Sectors
All Companies
Clear all filters
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Defence Therapeutics: Developing Next Generation Therapies to Combat Cancer with Propietary ACCUM™ Technology
January 2, 2023

Defence Therapeutics: Developing Next Generation Therapies to Combat Cancer with Propietary ACCUM™ Technology

Cancer treatment along with other infectious diseases need clinical solutions and this company may have one. BTV interviews Defense Therapeutics to learn about their proprietary ACCUM™ technology and its proven ability to deliver treatment drugs to diseased cells.

This is some text inside of a div block.
Algernon Pharmaceuticals: Advancing DMT into a Phase 1 Clinical Trial
October 28, 2022

CEO Clips - Algernon Pharmaceuticals: Advancing DMT into a Phase 1 Clinical Trial

Algernon is focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease.

This is some text inside of a div block.
Defence Therapeutics
October 26, 2022

Defence Therapeutics: Making a Global Impact

Defence Therapeutics is a Canadian Biotech company developing next generation bio-pharmaceutical innovations for various immuno-oncology (IO) and infectious diseases (ID) indications.

This is some text inside of a div block.
CEO Clips - Latin Metals
Metals & Mining
October 12, 2022

CEO Clips - Latin Metals: Prospect Generator in South America

Latin Metals is a mineral exploration company with a diversified portfolio of gold and copper exploration assets in South America.

This is some text inside of a div block.
No items found